Blue Horseshoe Stocks: HOME Recap & More

At Home Group, Inc. HOME 

On Friday morning, we closed out our premarket report with a fresh options trading idea for the HOME options chain, with the HOME 04/20 $30 Calls.

The idea paid instant dividends for our readers and ourselves as those calls traded in a very solid range from 1.20-3.75 on the day, giving us the chance at intraday gains of up to 213% There’s obviously plenty of time to continue tracking this play, but as it is, we’re extrmely pleased with its single session performance on Friday, which registered as the sixth biggest gainer on the NASDAQ.



Aytu BioScience, Inc. AYTU

Another target we selected last week for a bottom-watch play after noticing the chart setup and a string of insider buys, was AYTU. While it didn’t exactly blast off yet, we wanted to go over the move it did make, and reiterate our interest in tracking this play as we kick off this short trading week.

Subsequent to our alert, the stock traded in a range from .4118 to .51, a modest 24% rise, and still has tons of room to run. In fact, the company will need to promptly reach and maintain a 1.00 PPS or risk having NASDAQ forcibly de-list its stock.


Extended Watchlist:
AVID, DBX, GERN, JAGX, SRNE, VII, VKTX

Blue Horseshoe Stocks: NFLX Options & More

Sorrento Therapeutics, Inc. SRNE

Recently we’ve been delving back into our reports from late 2017, to review the ones that have made notable moves, and next up on the list SRNE.

We last signaled our interest in this as a bottom-watch play back on November 16th, and while it took a couple weeks for it to get out of its sideways-trading funk, the beginning of December brought the start of a fantastic run from an ultimate low of 2.15 that has persisted into the present. Yesterday the stock reached a new annual high of 8.05 (highest PPS since October ’16), marking an increase of 274%

This most recent push in what has definitely been a steady but sharp rise of the past six weeks may have been helped along by Celgene’s (CELG) buyout of Juno Therapeutics (JUNO), which share a market space with SRNE. The company also has some promising treatments in its pipeline.

Volume has recently been ramping up in a big way, too, so we’ll definitely continue to have an eye on this stock’s activity.


Netflix, Inc. NFLX – Options Idea

We’re always looking for a good opportunity to make some quick gains in the wake of a big company’s earnings, and NFLX is one that we’ve had quite a bit of experience with in that arena.

That’s why we’re going to enter an idea into the log this morning in the NFLX Weekly $247.50-255 Calls as the company posted a promising report including the addition of more than eight million new subscribers even despite its recent price increases.

Shares of NFLX broke a double top and are in blue skies, hitting a new all time high, so we’re very interested to track the ideas we’ve identified. They may be able to furnish us with some impressive gains.


Extended Watchlist:
CNET, ROKU, FATE, RMD, FNJN, VYGR

Blue Horseshoe Stocks: Bottom-Watch Play & More

Synergy Pharmaceuticals Inc. SGYP – Bottom Watch

We noticed SGYP start to sell off rapidly last week, after a poor earnings report and the pricing of a public offering on the stock with shares being offered at 2.58. Combined with the start of tax-loss selling season, and SGYP has approached extreme oversold territory.

We’ve now begun to take interest in this as a bottom watch play to monitor for a rebound in coming sessions, and it could ultimately be quite a recovery. We’ve got a stock that was trading for nearly seven dollars a share at the beginning of this year, beaten all the way down to new annual lows. If SGYP were to regain even a portion of the ground it’s lost in recent months, it would be worth our time to track it.


Wal-Mart Stores, inc. WMT – Options Idea

Looking at this morning’s premarket earnings calendar, it was WMT that jumped out at us the most, with a solid beat, and heightened guidance propelling the stock to a moderate gap up at the moment.

We’re going to formulate a quick options idea to try to take advantage of the situation. Walmart has been exceptionally bullish for most of this year, and is currently soaring into blue skies, setting a new annual high with every uptick.

We’re going to put the WMT Weekly $92-96 Calls on watch for the remainder of the week.


Extended Watchlist:
SRNE, MD, ADMP, QRHC, CREG, MD, RIOT, AFMD

Blue Horseshoe Stocks: SPY Options & More

SPDR S&P 500 ETF Trust – SPY

We’re projecting a solid day for the markets as a whole to close out the week as positive jobs numbers just hit, and usually in these cases, we like to use the SPY to get in on the action in the short term. We’re going to designate the SPY Weekly $247-248.50 Calls* as our contracts of interest.

Not only did hiring stay strong while jobless claims fell , but non-farm payroll gains exceeded expectations by a considerable margin, foreshadowing strength in US labor. To boot, the June Trade Balance figures came in and roughly $1.3B was shaved off of the expected trade deficit. All in all, these are several contributing factors that could certainly energize today’s session, and produce considerable intraday gain opportunities in our highlighted options.

______

GoPro, Inc. GPRO

While we’re thinking of potential quick-strike options plays, we’ve got to take a look at GPRO, which is gapping up in the premarket this morning on the heels of its Q2 earnings beat, and strong outlook. We’ve been familiar with GRPO options in the past, although it has been quite some time.

Prior to these bolstered figures as well as an analyst upgrade from Morgan Stanley this week, GPRO shares had been somewhat stuck in the mud for most of the summer so far. An extended rebound could be in the cards, but for now, we’ll just track today’s activity on the GPRO Weekly $9-10 Calls*.
______

*We don’t include mentions of weekly options contracts on a Friday without explicitly warning our readers every single time. Trading weekly options at the end of the week is an exceedingly risky proposition that should never be attempted by beginning or novice traders!


Extended Watchlist:
JSDA, PDLI, HDP, MTZ, SRNE, ARGS

Blue Horseshoe Stocks: BVTK Pops Again & More

Bravatek Solutions, Inc. BVTK

BVTK was among our mentions in Wednesday’s premarket report after it was unearthed in our chatroom* the previous morning before making a 500% move.  Those who missed that run got another chance right away as the stock ran from .0009-.0035 that afternoon, and topped out at .0041 to close out the short week on Friday. That added another two-day swing of 355% to the activity we had observed in BVTK, which was followed by a pullback to .0015.

Once again, to kick off the new trading week yesterday, BVTK began to run, returning to a high of .0034 on the day, representing yet another two-day upswing out of this volatile runner amounting to 127%  The stock ended the session having traded roughly three-and-a-half times its monthly average volume. Things could get very interesting if it can manage to crack resistance at the previous swing high of .0041.

The company filed an 8-K this morning as well , pertaining to an agreement with i3 Integrative Creative Solutions, pursuant to which i3 Integrative will promote and solicit commitments in the United States federal government military and civilian markets regarding the Company’s cybersecurity email software and telecom services. (>>View Filing)

*We encourage all of our readers to join in on our daily in-session live chats. To participate, simply create/sign into your Skype account and send a contact request to ‘stocksumo’.



Bank of America Corp BAC – Options Ideas 

Whenever we spot an opportunity to swoop in post-earnings with some options ideas, we jump on it right away, and that’s what we have with BAC this morning.

We haven’t highlighted this stock in quite awhile,but with a very solid beat on earnings and a small gap-up in the premarket, we’re going to want to signal a couple of short term contracts for observation in the BAC Weekly $22.50 and $23 Calls.

In the event that a more sustained rebound is in the cards, considering the fact that BAC was already coming off of a relative bottom just yesterday, we’ll have the BAC 05/12 $23.50 & $24 Calls on watch as well.



Bottom-Watchlist

We want to put an observational tag on both Sorrento Therapeutics, Inc. SRNE and OncoMed Pharmaceuticals, Inc. OMED.  Both of these stocks have taken serious beatings of late, and consequently, are in extreme oversold territory. Chances for recovery plays here seem quite high, so we’re going to watch for these to establish higher lows in sessions ahead.


Extended Watchlist:
JAMN, MYDX, CAB, SSYS, BIOC, NFLX